Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0E2OK
|
||||
Former ID |
DIB016921
|
||||
Drug Name |
MAL formulation
|
||||
Synonyms |
MAL formulation (oral, opiate dependence)
|
||||
Indication | Opiate dependence [ICD9: 304; ICD10:F11] | Phase 2 | [550591] | ||
Company |
D&A Pharma
|
||||
Target and Pathway | |||||
Target(s) | Mu-type opioid receptor | Target Info | Agonist | [550590] | |
Kappa-type opioid receptor | Target Info | Agonist | [550590] | ||
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Enkephalin releaseP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Opioid prodynorphin pathway | |||||
Pathway Interaction Database | IL4-mediated signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.